Exosomes for Polycystic Ovary Syndrome Treatment: Mechanisms and Therapeutic Potential - PubMed
4 hours ago
- #PCOS-treatment
- #personalized-medicine
- #exosome-therapy
- Polycystic ovary syndrome (PCOS) is a major health concern for women of reproductive age, leading to infertility and metabolic dysfunction.
- Current treatments include lifestyle modifications, pharmacological therapies (e.g., oral contraceptives, metformin), and procedures like laparoscopic ovarian drilling (LOD), but they often have adverse effects and high relapse rates.
- Exosome-based therapies are emerging as promising treatments for PCOS, with potential sources including adipose-derived mesenchymal stem cells, menstrual blood-derived stem cells, and human umbilical cord-derived mesenchymal stem cells.
- Exosomes, as nanosized extracellular vesicles, offer strong targeting capacity and low immunogenicity, carrying bioactive molecules that can address PCOS mechanisms.
- Potential therapeutic mechanisms of exosomes include suppressing chronic inflammation, enhancing mitochondrial function, inhibiting apoptosis, modulating angiogenesis, and improving metabolic disturbances.
- Challenges in clinical translation include lack of standardization, high production costs, and limited clinical data on safety and efficacy.
- Overcoming these challenges could lead to personalized exosome treatments for PCOS.